Sun Pharma to acquire InSite Vision?

Deal said to be close to Rs. 300 crore, says reports.

According to report in ET Now, India's leading pharmaceutical company Sun Pharma is set  to acquire InSite Vision.

Sun Pharmaceuticals Industries Ltd closed at Rs. 857.05, up by 11 points or 1.3% from its previous closing of Rs. 846.05 on the BSE.

On Monday, the scrip opened at Rs. 854.2 and has touched a high and low of Rs. 858.95 and Rs. 845.35 respectively. So far 2590701 shares were traded on the counter. The current market cap of the company is Rs. 206248.75 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.8 on 07-Apr-2015 and a 52 week low of Rs. 748 on 26-Sep-2014. Last one week high and low of the scrip stood at Rs. 860 and Rs. 815 respectively.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 31.51 % and 13.78 % respectively.

The stock is currently trading above its 200 DMA.